Pre-treatment bone turnover does not influence the level of the response to alendronate in postmenopausal osteoporosis at the bone tissue level

P. Chavassieux, J.P. Roux, R. Chapurlat

Open source

DOI
10.1007/s00198-023-06972-8
Published
2023-12-22
Container
Osteoporosis International
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00198-023-06972-8,
  title = {Pre-treatment bone turnover does not influence the level of the response to alendronate in postmenopausal osteoporosis at the bone tissue level},
  author = {P. Chavassieux and J.P. Roux and R. Chapurlat},
  year = {2023},
  journal = {Osteoporosis International},
  doi = {10.1007/s00198-023-06972-8},
  url = {https://doi.org/10.1007/s00198-023-06972-8}
}

RIS

TY  - JOUR
TI  - Pre-treatment bone turnover does not influence the level of the response to alendronate in postmenopausal osteoporosis at the bone tissue level
AU  - P. Chavassieux
AU  - J.P. Roux
AU  - R. Chapurlat
PY  - 2023
JO  - Osteoporosis International
DO  - 10.1007/s00198-023-06972-8
UR  - https://doi.org/10.1007/s00198-023-06972-8
ER  - 

APA

Chavassieux, P., Roux, J., & Chapurlat, R. (2023). Pre-treatment bone turnover does not influence the level of the response to alendronate in postmenopausal osteoporosis at the bone tissue level. Osteoporosis International. https://doi.org/10.1007/s00198-023-06972-8

Source records